Dr. Sainath Bhethanabhotla-Medical Oncologist

Dr. Sainath Bhethanabhotla, Medical Oncologist

MBBS, MD, DM (Medical Oncology)

Specializations

  • Medical Oncologist

  • Oncologist

Qualifications

  • MBBS - Osmania Medical College Verified
  • MD - Internal Medicine - All India Institute Of Medical Sciences - New Delhi Verified
  • DM - Medical Oncology - All India Institute Of Medical Sciences - New Delhi Verified

Experiences

  • Senior Resident - Department of Medical Oncology AIIMS - New Delhi
  • Resident Super Specialist MNJ Institute of Oncology and Regional Cancer Center - Hyderabad
  • Consultant Medical Oncology Krishna Institute of Medical Sciences
  • Consultant Medical Oncologist American Oncology Institute - Hyderabad
  • Consultant Medical Oncologist Star Hospitals - Nanakramguda - Currently Working

Awards and Recognitions

  • “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies held in Chicago for the abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 patients”- 2016
  • Received Scholarship for Oral presentation in SIOP-2015- Cape Town- South Africa for the abstract “Outcome Of Pediatric Hodgkin Lymphoma Treated With ABVD: A Multicentric Analysis Of 335 Patients”
  • Won Sorel Catherine Prize for Best Post Graduate in Pediatrics for the Year 2012
  • Stood 2nd in NNF Gold Medal Paper for the Year 2012(1)

Paper Presentations

  • Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8;IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated with ABVD and Predictors of Inferior Survival: A Multicenter Study of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644
  • Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post- Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Bakhshi S. Presence of Risk Factors Does Not Affect Outcome in Early Stage Pediatric Hodgkin Lymphoma Treated with ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845
  • Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role of (18)F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer - 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.
  • Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma of the Prostate: A Report of Two Cases with Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459
  • Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma with Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644
  • Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect of Position of Infant During Phototherapy in Management of Hyperbilirubinemia in Late Preterm and Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183
  • Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation for Multiple Myeloma: Long-Term Results. The National Medical Journal of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786
  • Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4;Online First. IMPACT FACTOR: 1.046
  • Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is it Practice Changing Facts and Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79

Report an error

Dr. Sainath Bhethanabhotla Practice Location

location-icon

8-2-596/5

Road. No. 10

Banjara Hills, Hyderabad

Get directions

time-icon

OP Timings

Mon, 

Wed, 

Fri

03:00 pm - 05:00 pm
...

Fee : 900

location-icon

Survey No.74

Financial District

Nanakramguda, Hyderabad

Get directions

time-icon

OP Timings

Mon - Sat

09:30 am - 02:00 pm
...

Fee : 750

Write a review for Dr. Sainath Bhethanabhotla

Which clinic or hospital you visited

empty

I Recommend this Doctor for

How was your experience

Write your experience aboutDr. Sainath Bhethanabhotla

skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

  • Home
  • Search
  • Doctors
  • Hospitals